C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
4.000
-0.030 (-0.74%)
At close: Aug 21, 2026, 4:00 PM EDT
4.051
+0.051 (1.28%)
After-hours: Aug 21, 2026, 7:55 PM EDT
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $492.1 million as of August 21, 2026. Its market cap has increased by 165.94% in one year.
Market Cap
492.10M
Enterprise Value
248.51M
1-Year Change
165.94%
Ranking
Category
Stock Price
$4.00
ChartMarket Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $492.10M, a decrease of -36.32%. That is a compound annual growth rate of -7.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 492.10M | 165.85% |
| Dec 31, 2025 | 185.11M | -27.16% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MapLight Therapeutics | 520.82M |
| Kyverna Therapeutics | 502.79M |
| Relmada Therapeutics | 494.95M |
| Evommune | 492.48M |
| Rezolute | 486.82M |
| BlossomHill Therapeutics | 484.17M |
| Q32 Bio | 472.14M |
| Ocugen | 471.36M |